160 related articles for article (PubMed ID: 38438726)
1. Systolic blood pressure visit-to-visit variability and outcomes in Asian patients with atrial fibrillation.
Chichareon P; Methavigul K; Lip GYH; Krittayaphong R
Hypertens Res; 2024 Jun; 47(6):1479-1489. PubMed ID: 38438726
[TBL] [Abstract][Full Text] [Related]
2. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management).
Proietti M; Romiti GF; Olshansky B; Lip GYH
Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568
[TBL] [Abstract][Full Text] [Related]
3. Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry.
Krittayaphong R; Pumprueg S; Ratanasumawong K; Sairat P; Lip GYH;
Clin Interv Aging; 2021; 16():1835-1846. PubMed ID: 34675498
[TBL] [Abstract][Full Text] [Related]
4. Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL-AF Registry.
Krittayaphong R; Winijkul A; Methavigul K; Lip GYH
J Am Heart Assoc; 2023 Feb; 12(3):e028463. PubMed ID: 36695303
[TBL] [Abstract][Full Text] [Related]
5. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
6. Assessment of visit-to-visit variability in systolic blood pressure over 5 years and phasic left atrial function by two-dimensional speckle-tracking echocardiography.
Tanaka S; Segawa T; Noda T; Tsugita N; Fuseya T; Kawaguchi T; Iwama M; Watanabe S; Minagawa T; Minatoguchi S; Hiroyuki O
Heart Vessels; 2021 Jun; 36(6):827-835. PubMed ID: 33462685
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Hypertension and Systolic Blood Pressure With the Risk of Stroke or Bleeding in Patients With Atrial Fibrillation: The Fushimi AF Registry.
Ishii M; Ogawa H; Unoki T; An Y; Iguchi M; Masunaga N; Esato M; Chun YH; Tsuji H; Wada H; Hasegawa K; Abe M; Akao M
Am J Hypertens; 2017 Nov; 30(11):1073-1082. PubMed ID: 28575205
[TBL] [Abstract][Full Text] [Related]
8. Time in target range of systolic blood pressure and clinical outcomes in atrial fibrillation patients: results of the COOL-AF registry.
Krittayaphong R; Chichareon P; Komoltri C; Yindeengam A; Lip GYH
Sci Rep; 2024 Jan; 14(1):805. PubMed ID: 38191585
[TBL] [Abstract][Full Text] [Related]
9. Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry).
Vemulapalli S; Inohara T; Kim S; Thomas L; Piccini JP; Patel MR; Chang P; Fonarow GC; Ezekowitz MD; Hylek E; Go AS; Kowey PR; Mahaffey KW; Gersh BJ; Peterson ED
Am J Cardiol; 2019 May; 123(10):1628-1636. PubMed ID: 30846214
[TBL] [Abstract][Full Text] [Related]
10. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative.
Shimbo D; Newman JD; Aragaki AK; LaMonte MJ; Bavry AA; Allison M; Manson JE; Wassertheil-Smoller S
Hypertension; 2012 Sep; 60(3):625-30. PubMed ID: 22753206
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.
Böhm M; Brueckmann M; Eikelboom JW; Ezekowitz M; Fräßdorf M; Hijazi Z; Hohnloser SH; Mahfoud F; Schmieder RE; Schumacher H; Wallentin L; Yusuf S
Eur Heart J; 2020 Aug; 41(30):2848-2859. PubMed ID: 32385506
[TBL] [Abstract][Full Text] [Related]
12. Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial.
Park S; Bergmark BA; Shi M; Lanz HJ; Chung N; Ruff CT; Antman EM; Braunwald E; Giugliano RP
Hypertension; 2019 Sep; 74(3):597-605. PubMed ID: 31352829
[TBL] [Abstract][Full Text] [Related]
13. Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Stroke; 2020 Feb; 51(2):416-423. PubMed ID: 31813363
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial.
Vemulapalli S; Hellkamp AS; Jones WS; Piccini JP; Mahaffey KW; Becker RC; Hankey GJ; Berkowitz SD; Nessel CC; Breithardt G; Singer DE; Fox KA; Patel MR
Am Heart J; 2016 Aug; 178():74-84. PubMed ID: 27502854
[TBL] [Abstract][Full Text] [Related]
15. Visit-to-Visit Heart Rate Variability in the Prediction of Clinical Outcomes of Patients with Atrial Fibrillation.
Krittayaphong R; Boonyapisit W; Sairat P; Lip GYH
Thromb Haemost; 2023 Sep; 123(9):920-929. PubMed ID: 37116533
[TBL] [Abstract][Full Text] [Related]
16. Low correlation between visit-to-visit variability and 24-h variability of blood pressure.
Muntner P; Shimbo D; Diaz KM; Newman J; Sloan RP; Schwartz JE
Hypertens Res; 2013 Nov; 36(11):940-6. PubMed ID: 23784506
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin in Elderly Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Chiang CE; Liao JN; Chen TJ; Lip GYH; Chen SA
Chest; 2020 May; 157(5):1266-1277. PubMed ID: 31809694
[TBL] [Abstract][Full Text] [Related]
18. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy and home blood pressure-associated risk for stroke/bleeding events in elderly patients with non-valvular atrial fibrillation: the sub-cohort study of ANAFIE registry.
Kario K; Hasebe N; Okumura K; Yamashita T; Akao M; Atarashi H; Ikeda T; Koretsune Y; Shimizu W; Suzuki S; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Morishima Y; Takita A; Inoue H
Hypertens Res; 2023 Dec; 46(12):2575-2582. PubMed ID: 37433904
[TBL] [Abstract][Full Text] [Related]
20. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
